Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Summary

This reports provides a data-driven overview of the current and future competitive landscape in Waldenstrom Macroglobulinemia therapeutics.

Synopsis

  • In 2022, there will be more than 14,000 incident cases of WM across 16 pharmaceutical markets.
  • There are three leading marketed drugs for the treatment of WM, and Beigene is a key player in the disease space.
  • A total of six pipeline drugs for WM are in late-stage (Phase III and Pre-registration) development.
  • Commercial sponsors dominate clinical trial development in WM, with the US emerging as the key countries for conducting trials in WM.
  • Deals involving partnerships were the most common type of deals globally, except in South America.
  • Therapeutic options for WM patients continue to be limited, and no new therapy is expected to reach the US market in the next 12 months.
Scope

GlobalData’s combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -
  • Disease Landscape
  • Disease Overview
  • Epidemiology Overview
  • Treatment Overview
  • Marketed Products Assessment
  • Breakdown by Mechanism of Action, Molecule Type and Route of Administration
  • Product Profiles with Sales Forecast
  • Pipeline Assessment
  • Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
  • Late-to-mid-stage Pipeline Drugs
  • Phase Transition Success Rate and Likelihood of Approval
  • Clinical Trials Assessment
  • Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
  • Enrolment Analytics, Site Analytics, Feasibility Analysis
  • Deals Landscape
  • Mergers, Acquisitions, and Strategic Alliances by Region
  • Overview of Recent Deals
  • Commercial Assessment
  • Key Market Players
  • Future Market Catalysts
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Waldenstrom Macroglobulinemia market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Waldenstrom Macroglobulinemia market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.


  • Report Scope
  • Abbreviations
  • Key Findings
  • Disease Overview
  • Epidemiology Overview
    • Epidemiology Overview - Total Incident Cases of WM in 2022 and 2027
      • Table Epidemiology Overview - Total Incident Cases of WM in 2022 and 2027
  • Treatment Overview
    • Treatment Guidelines
  • Marketed Drugs Assessment
    • Marketed Drugs - Leading Marketed Drugs in WM
    • Marketed Drugs - Overview by Mechanism of Action
    • Marketed Drugs - Overview by Route of Administration
    • Marketed Drug Profile - AbbVie's Imbruvica
    • Marketed Drug Profile - BeiGene's Brukinsa
    • Marketed Drug Profile - Ono Pharmaceutical's Velexbru
  • Pipeline Drugs Assessment
    • Pipeline Drugs Overview - Phase III Pipeline Drugs in WM
    • Pipeline Drugs - Overview by Development Stage
    • Pipeline Drugs - Overview by Molecule Type
    • Pipeline Drugs - Overview by Mechanism of Action
    • Pipeline Drugs - Overview by Route of Administration
    • Pipeline Drugs - Drug-Specific Phase Transition Success Rate and Likelihood of Approval in WM
    • Pipeline Drugs - Phase Transition Success Rates and Likelihood of Approval in Oncology and WM
  • Clinical Trials Assessment
    • Clinical Trials in WM - Historical Overview
    • Clinical Trials in WM - Overview by Phase
    • Clinical Trials in WM - Overview by Status
    • Clinical Trials in WM - Overview by Phase for Ongoing and Planned Trials
    • Clinical Trials in WM - Trials with a Virtual Component
    • Clinical Trials in WM - Geographic Overview
    • Clinical Trials in WM - Single-Country and Multinational Trials by Region
    • Clinical Trials in WM - Top 20 Sponsors with Breakdown by Phase
    • Clinical Trials in WM - Top 20 Sponsors with Breakdown by Status
    • Clinical Trials in WM - Overview by Endpoint Status
    • Clinical Trials in WM - Overview by Race and Ethnicity
    • Clinical Trials in WM - Enrollment Data
    • Clinical Trials in WM - Overview of Sites by Geography
    • Clinical Trials in WM - Top 20 Countries for Trial Sites
    • Clinical Trials in WM - Top 20 Sites Globally
    • Clinical Trials - Feasibility Analysis: Geography Overview
      • Table Clinical Trials - Feasibility Analysis: Geography Overview
    • Clinical Trials - Feasibility Analysis: Benchmark Models for WM
  • Deals Landscape
    • Deals Landscape - Mergers, Acquisitions, and Strategic Alliances in WM by Region
    • Deals Landscape - Recent Mergers, Acquisitions, and Strategic Alliances in WM
  • Commercial Assessment
    • Commercial Assessment - Key Market Players in WM
  • Future Market Catalysts
    • Future Market Catalysts - Upcoming Market Catalysts in WM
  • Appendix
    • Methodology
    • Methodology - Sales Forecasts
    • Methodology - Phase Transition Success Rate and Likelihood of Approval Analysis
    • About the Authors
  • Contact Us
    • Contact Us - A Global Network of Offices

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings